|Assembly Actions - Lowercase
Senate Actions - UPPERCASE
|Jul 15, 2011||
|Jul 08, 2011||
delivered to governor
|Jun 06, 2011||
returned to assembly
3rd reading cal.829
substituted for s3102
|Jun 06, 2011||
substituted by a372
|Jun 01, 2011||
advanced to third reading
|May 25, 2011||
2nd report cal.
|May 24, 2011||
1st report cal.829
|May 10, 2011||
reported and committed to health
|Feb 08, 2011||
referred to consumer protection
senate Bill S3102Signed By Governor
Restricts retail sale of ipecac syrup to behind the pharmacy counter or under manager control
Archive: Last Bill Status Via A372 - Signed by Governor
- In Committee
- On Floor Calendar
- Passed Senate
- Passed Assembly
- Delivered to Governor
- Signed by Governor
view actions (12)
Jun 6, 2011 - floor VoteA372610floor61Aye0Nay1Absent0Excused0Abstained
show floor vote details
Floor Vote: Jun 6, 2011aye (61)
May 24, 2011 - Health committee VoteS3102150committee15Aye0Nay2Aye with Reservations0Absent0Excused0Abstained
May 10, 2011 - Consumer Protection committee VoteS310290committee9Aye0Nay1Aye with Reservations0Absent0Excused0Abstained
- show floor vote details
S3102 - Bill Details
S3102 - Bill Texts
Directs the commissioner of health to require that access to retail sale of ipecac syrup shall not be unrestricted; requires placement behind the pharmacy or only accessible through the manager of a retail establishment.
view sponsor memo
TITLE OF BILL:
to amend the general business law, in relation to restricting access to
To restrict the access to retail sale of ipecac.
SUMMARY OF PROVISIONS:
Section 1 amends the general business law by adding a new section
391-r which restricts the access to retail sale of ipecac.
Ipecac syrup has long been distributed for emergency use to induce
vomiting in poisoning cases. Recent years have seen an increase in.
ipecac abuse among sufferers of bulimia, anorexia and binge eating
disorder. While ipecac is often effective in inducing emesis and
decreasing the absorption of poisonous toxins, its side effects and
abuse potential offer cause for concern.
Repeated use and abuse of ipecac syrup has been linked to skin
conditions, cardiac and skeletal muscle weakness, and electrolyte
imbalance, with sometimes fatal results. An emerging consensus among
many professional medical groups is that syrup of ipecac should no
longer be used routinely as a poison treatment in the home. U.S.A.
poison centers have also markedly reduced their use of ipecac syrup
over the previous decade and, on June 12, 2003, the Food and Drug
Administration's Nonprescription Drugs Advisory Committee
recommended by a vote of six to four that the FDA rescind ipecac's
This legislation seeks to regulate the availability of, and access to,
this noxious powerful emetic.
05/06/09 passed Assembly
02/01/10 passed Assembly
01/07/09 referred to health
01/22/09 reported referred to codes
04/23/09 advanced to third reading cal.349
05/06/09 passed assembly
05/06/09 delivered to senate
05/06/09 REFERRED TO HEALTH
01/06/10 DIED IN SENATE
01/06/10 RETURNED TO ASSEMBLY
01/06/10 ordered to third reading cal.42
02/01/10 passed assembly
02/01/10 delivered to senate
02/01/10 REFERRED TO HIGHER EDUCATION
03/08/10 recalled from senate
03/08/10 RETURNED TO ASSEMBLY
03/08/10 vote reconsidered - restored to third reading
03/08/10 amended on third reading (t) 544a
03/22/10 amended on third reading 544b
05/11/10 repassed assembly
05/11/10 returned to senate
None to the State.
This act shall take effect immediately; provided, however, that the
rules and regulations necessary to implement section one of this act
shall be promulgated and take effect on or before the one hundred
eightieth day after this act shall have become law.
view full text
S T A T E O F N E W Y O R K ________________________________________________________________________ 3102 2011-2012 Regular Sessions I N S E N A T E February 8, 2011 ___________ Introduced by Sen. GALLIVAN -- read twice and ordered printed, and when printed to be committed to the Committee on Consumer Protection AN ACT to amend the general business law, in relation to restricting access to ipecac syrup THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The general business law is amended by adding a new section 391-r to read as follows: S 391-R. RESTRICTED ACCESS TO RETAIL SALE OF IPECAC. 1. ANY RETAIL ESTABLISHMENT THAT SELLS ANY PRODUCT OR PRODUCTS CONTAINING AS THE ONLY ACTIVE INGREDIENT IPECAC, SHALL LIMIT ACCESS TO SUCH PRODUCTS IN A MANNER DESIGNED TO PREVENT THE MISUSE OR ABUSE OF SUCH PRODUCTS. SUCH LIMITATIONS SHALL INCLUDE REMOVING SUCH PRODUCTS FROM SHELVES AND OTHER LOCATIONS THAT ARE DIRECTLY ACCESSIBLE BY CUSTOMERS, AND PLACING SUCH PRODUCTS BEHIND A PHARMACY COUNTER SO THAT A CONSUMER MUST REQUEST SUCH PRODUCTS IN ORDER TO OBTAIN SUCH PRODUCTS FROM AN EMPLOYEE WORKING IN THE PHARMACY. IF THE RETAIL ESTABLISHMENT WISHES TO SELL SUCH PRODUCTS BUT DOES NOT MAINTAIN A PHARMACY AT THAT RETAIL LOCATION, SUCH PRODUCTS SHALL BE MADE SECURE SUCH THAT THEY MAY ONLY BE ACCESSED BY A MANAGER, ASSISTANT MANAGER, ACTING MANAGER OR OTHER SUPERVISORY PERSONNEL AT SUCH LOCATION. 2. AS USED IN THIS SECTION "RETAIL ESTABLISHMENT" MEANS EVERY VENDOR THAT IN THE REGULAR COURSE OF BUSINESS SELLS PRODUCTS CONTAINING IPECAC AT RETAIL DIRECTLY TO THE PUBLIC INCLUDING, BUT NOT LIMITED TO, PHARMA- CIES, GROCERY STORES, AND OTHER RETAIL STORES. S 2. This act shall take effect immediately; provided, however, that the rules and regulations necessary to implement section one of this act shall be promulgated and take effect on or before the one hundred eight- ieth day after this act shall have become a law. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD01091-01-1
Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.
By contributing or voting you agree to the Terms of Participation and verify you are over 13.